Document is current
Any future updates will be listed below
-
Authors
Schilperoort, Maaike https://orcid.org/0000-0002-8597-7675
van Dam, Andrea D
Hoeke, Geerte
Shabalina, Irina G https://orcid.org/0000-0002-2915-6450
Okolo, Anthony
Hanyaloglu, Aylin C
Dib, Lea H
Mol, Isabel M
Caengprasath, Natarin
Chan, Yi‐Wah
Damak, Sami
Miller, Anne Reifel
Coskun, Tamer
Shimpukade, Bharat
Ulven, Trond
Kooijman, Sander
Rensen, Patrick CN
Christian, Mark https://orcid.org/0000-0002-1616-4179
-
Funding
Funding for this research was provided by:
EU FP7 project DIABAT (HEALTH‐F2‐2011‐278373)
Genesis Research Trust
Danish Council for Strategic Research (11‐116196)
Board of Directors of Leiden University Medical Center
Leiden University Fund
Netherlands Cardiovascular Research Initiative (CVON2011‐9 GENIUS)
Rembrandt Institute of Cardiovascular Science
Dutch Heart Foundation (2009T038)
RCUK | Biotechnology and Biological Sciences Research Council (BB/H020233/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/P008879/1)
Eli Lilly
- License Information
-
More Information
Article History
Received: 23 May 2017
Revised: 20 December 2017
Accepted: 22 December 2017
First Online: 17 January 2018
Conflict of interest
: The authors declare that they have no conflict of interest.
